Safety of folic acid

Annals of the New York Academy of Sciences

Volumn 1414, Issue 1, 2018, Pages 59-71

  Field, Martha S ^a   Stover, Patrick J ^a  

^a Cornell University ^*  (United States)

Author keywords

cancer; folate; folic acid; neural tube defects; safety

Indexed keywords

FOLIC ACID;

ARTICLE; AUTISM; CARDIOVASCULAR DISEASE; COGNITION; DIABETES MELLITUS; DRUG SAFETY; FOLIC ACID DEFICIENCY; HUMAN; HYPERSENSITIVITY; MALIGNANT NEOPLASM; MORTALITY; NEURAL TUBE DEFECT; NONHUMAN; OUTCOME ASSESSMENT; PUBLIC HEALTH; RISK ASSESSMENT; THYROID DISEASE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 85034621610     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13499     Document Type: Article

References (76)

1. Bibbins-Domingo, K., D.C. Grossman, S.J. Curry, et al. 2017. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. JAMA 317: 183–189.
2. Gomes, S., C. Lopes & E. Pinto. 2016. Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO. Public Health Nutr. 19: 176–189.
3. Moussa, H.N., S. Hosseini Nasab, Z.A. Haidar, et al. 2016. Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. Future Sci. OA 2: FSO116.
4. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 338: 131–137.
5. Czeizel, A. & I. Dudas. 1992. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327: 1832–1835.
6. Smithells, R.W., S. Sheppard, J. Wild & C.J. Schorah. 1989. Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 2: 498–499.
7. Nevin, N.C. & M.J. Seller. 1990. Prevention of neural-tube-defect recurrences. Lancet 335: 178–179.
8. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 1998. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Institute of Medicine (US) Food and Nutrition Board, Washington, DC.
9. Centers for Disease Control. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 41(RR-14): 1–7.
10. Finer, L.B. & S.K. Henshaw. 2006. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect. Sex. Reprod. Health 38: 90–96.
11. Crozier, S.R., S.M. Robinson, S.E. Borland, et al. 2009. Do women change their health behaviours in pregnancy? Findings from the Southampton Women's Survey. Paediatr. Perinat. Epidemiol. 23: 446–453.
12. Food Fortification Initiative. 2016. Say Hello to a Fortified Future, 2016 in Review. Atlanta, GA: Food Fortification Initiative.
13. Searby, L. 2016. Folic acid fortification: the current global state of play. Accessed August 30, 2017. http://www.nutraingredients.com/Regulation-Policy/Folic-acid-fortification-The-current-global-state-of-play.
14. Hopkins, S.M., M.J. Gibney, A.P. Nugent, et al. 2015. Impact of voluntary fortification and supplement use on dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults. Am. J. Clin. Nutr. 101: 1163–1172.
15. Daly, L.E., P.N. Kirke, A. Molloy, et al. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702.
16. Crider, K.S., O. Devine, L. Hao, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349: g4554.
17. Food and Drug Administration-HHS. 1993. Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Fed. Reg. 58: 53305–53312.
18. Bailey, L.B. 2004. Folate and vitamin B12 recommended intakes and status in the United States. Nutr. Rev. 62: S14–S20; discussion S21.
19. Yang, Q., M.E. Cogswell, H.C. Hamner, et al. 2010. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am. J. Clin. Nutr. 91: 64–72.
20. Carmel, R. & C.S. Johnson. 1978. Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N. Engl. J. Med. 298: 647–650.
21. Hannibal, L., V. Lysne, A.L. Bjorke-Monsen, et al. 2016. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency. Front. Mol. Biosci. 3: 27.
22. Kriebel, D. & J. Tickner. 2001. Reenergizing public health through precaution. Am. J. Public Health 91: 1351–1355.
23. Goldstein, B.D. 2001. The precautionary principle also applies to public health actions. Am. J. Public Health 91: 1358–1361.
24. World Health Organization. 2015. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization.
25. Yetley, E.A., A.J. MacFarlane, L.S. Greene-Finestone, et al. 2017. Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group. Am. J. Clin. Nutr. 105: 249S–285S.
26. Detrait, E.R., T.M. George, H.C. Etchevers, et al. 2005. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol. Teratol. 27: 515–524.
27. Gelineau-van Waes, J., M.A. Rainey, J.R. Maddox, et al. 2012. Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720. Birth Defects Res. A Clin. Mol. Teratol. 94: 790–803.
28. Mazumdar, M., M.O. Ibne Hasan, R. Hamid, et al. 2015. Arsenic is associated with reduced effect of folic acid in myelomeningocele prevention: a case control study in Bangladesh. Environ. Health 14: 34.
29. Suh, J.R., A.K. Herbig & P.J. Stover. 2001. New perspectives on folate catabolism. Annu. Rev. Nutr. 21: 255–282.
30. Suitor, C.W. & L.B. Bailey. 2000. Dietary folate equivalents: interpretation and application. J. Am. Diet. Assoc. 100: 88–94.
31. Bailey, S.W. & J.E. Ayling. 2009. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci. USA 106: 15424–15429.
32. Pfeiffer, C.M., M.R. Sternberg, Z. Fazili, et al. 2015. Unmetabolized folic acid is detected in nearly all serum samples from US children, adolescents, and adults. J. Nutr. 145: 520–531.
33. Wright, A.J., P.M. Finglas, J.R. Dainty, et al. 2005. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: a revised hypothesis of the primary site of PteGlu metabolism in humans. J. Nutr. 135: 619–623.
34. West, A.A., J. Yan, C.A. Perry, et al. 2012. Folate-status response to a controlled folate intake in nonpregnant, pregnant, and lactating women. Am. J. Clin. Nutr. 96: 789–800.
35. Carmel, R. 2008. Nutritional anemias and the elderly. Semin. Hematol. 45: 225–234.
36. Agamanolis, D.P., E.M. Chester, M. Victor, et al. 1976. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology 26: 905–914.
37. Yeung, L., Q. Yang & R.J. Berry. 2008. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 300: 2486–2487.
38. Scientific Advisory Committee on Nutrition. 2017. Draft–update on folic acid. GOV.UK.
39. Troen, A.M., B. Mitchell, B. Sorensen, et al. 2006. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr. 136: 189–194.
40. Kelly, P., J. McPartlin, M. Goggins, et al. 1997. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 65: 1790–1795.
41. Pfeiffer, C.M., M.R. Sternberg, Z. Fazili, et al. 2015. Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011–2012. Br. J. Nutr. 113: 1965–1977.
42. Fox, J.T. & P.J. Stover. 2008. Folate-mediated one-carbon metabolism. Vitam. Horm. 79: 1–44.
43. Yetley, E.A., C.M. Pfeiffer, K.W. Phinney, et al. 2011. Biomarkers of folate status in NHANES: a roundtable summary. Am. J. Clin. Nutr. 94: 303S–312S.
44. Misselbeck, K., L. Marchetti, M.S. Field, et al. 2017. A hybrid stochastic model of folate-mediated one-carbon metabolism: effect of the common C677T MTHFR variant on de novo thymidylate biosynthesis. Sci. Rep. 7: 797.
45. Boyles, A.L., E.A. Yetley, K.A. Thayer & P.M. Coates. 2016. Safe use of high intakes of folic acid: research challenges and paths forward. Nutr. Rev. 74: 469–474.
46. National Toxicology Program. 2015. NTP monograph: identifying research needs for assessing safe use of high intakes of folic acid. Research Triangle Park, NC: National Toxicology Program. Accessed September 28, 2017. https://ntp.niehs.nih.gov/ntp/ohat/folicacid/final_monograph_508.pdf.
47. Food Safety Authority of Ireland. 2016. Update report on folic acid and the prevention of birth defects in Ireland. Dublin: Food Safety Authority of Ireland.
48. Food and Drug Administration HHS. 2016. Food additives permitted for direct addition to food for human consumption; folic acid. Final rule. Fed. Reg. 81: 22176–22183.
49. Norwegian Scientific Committee for Food Safety. 2015. Risk assessment of folic acid and food supplements; opinion of the panel on nutrition, dietetic products, novel food and allergy of the Norwegian Scientific Committee for Food Safety (VKM). Oslo: Norwegian Scientific Committee for Food Safety.
50. European Food Safety Authority. 2014. Update report on folic acid and the prevention of birth defects in Ireland. Parma: European Food Safety Authority.
51. Smith, A.D., Y.I. Kim & H. Refsum. 2008. Is folic acid good for everyone? Am. J. Clin. Nutr. 87: 517–533.
52. Mason, J.B. 2009. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr. Rev. 67: 206–212.
53. Kim, Y.I. 2006. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55: 1387–1389.
54. Vollset, S.E., R. Clarke, S. Lewington, et al. 2013. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 381: 1029–1036.
55. Qin, T., M. Du, H. Du, et al. 2015. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials. Sci. Rep. 5: 12044.
56. Mason, J.B. 2011. Folate consumption and cancer risk: a confirmation and some reassurance, but we're not out of the woods quite yet. Am. J. Clin. Nutr. 94: 965–966.
57. /+ mouse model. Mut. Res. [Epub ahead of print.]
58. Palmer, A.M., E. Kamynina, M.S. Field & P.J. Stover. 2017. Folate rescues vitamin B12 depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability. Proc. Natl. Acad. Sci. USA. 114: E4095–E4102.
59. Lindenbaum, J., E.B. Healton, D.G. Savage, et al. 1995. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. 1988. Nutrition 11: 181; discussion 180, 182.
60. Morris, M.S., P.F. Jacques, I.H. Rosenberg & J. Selhub. 2007. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 85: 193–200.
61. Morris, M.S., J. Selhub & P.F. Jacques. 2012. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the Framingham Heart Study. J. Am. Geriatr. Soc. 60: 1457–1464.
62. Miller, J.W., M.G. Garrod, L.H. Allen, et al. 2009. Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am. J. Clin. Nutr. 90: 1586–1592.
63. Young, S.S. & A. Karr. 2011. Deming, data and observational studies. Significance 8:116–120.
64. Brito, A., R. Verdugo, E. Hertrampf, et al. 2016. Vitamin B-12 treatment of asymptomatic, deficient, elderly Chileans improves conductivity in myelinated peripheral nerves, but high serum folate impairs vitamin B-12 status response assessed by the combined indicator of vitamin B-12 status. Am. J. Clin. Nutr. 103: 250–257.
65. Yajnik, C.S., S.S. Deshpande, A.A. Jackson, et al. 2008. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51: 29–38.
66. Stewart, C.P., P. Christian, K.J. Schulze, et al. 2009. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal. J. Nutr. 139: 1575–1581.
67. Cooney, C.A., A.A. Dave & G.L. Wolff. 2002. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 132(8 Suppl.): 2393S–2400S.
68. Dolinoy, D.C., J.R. Weidman, R.A. Waterland & R.L. Jirtle. 2006. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 114: 567–572.
69. Morgan, H.D., H.G.E. Sutherland, D.I.K. Martin & E. Whitelaw. 1999. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 23: 314–318.
70. Waterland, R.A. & R.L. Jirtle. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23: 5293–5300.
71. Modabbernia, A., E. Velthorst & A. Reichenberg. 2017. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol. Autism 8: 13.
72. Gao, Y., C. Sheng, R.-H. Xie, et al. 2016. New perspective on impact of folic acid supplementation during pregnancy on neurodevelopment/autism in the offspring children—a systematic review. PLoS One 11: e0165626.
73. Zhao, M., X. Wang, M. He, et al. 2017. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 48:1183–1190.
74. Xu, A., X. Cao, Y. Lu, et al. 2016. A meta-analysis of the relationship between maternal folic acid supplementation and the risk of congenital heart defects. Int. Heart J. 57: 725–728.
75. Qin, X., J. Li, J.D. Spence, et al. 2016. Folic acid therapy reduces the first stroke risk associated with hypercholesterolemia among hypertensive patients. Stroke 47: 2805–2812.
76. Liu, S., K.S. Joseph, W. Luo, et al. 2016. Effect of folic acid food fortification in Canada on congenital heart disease subtypes. Circulation 134: 647–655.